Vendor, Pittsburgh, PA
Qrono, Inc.
UEI S8NSYCMSNF79, CAGE 6BR38
1 award and $0 obligated between July 15, 2024 and July 15, 2024, 100% under full and open competition, against 10.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023C00034Definitive Contract, July 15, 2024, Full and Open Competition, 10 offers | National Institutes of Health NiaidNational Institutes of Health | Screening for Tolerogenic Adjuvants to Enhance Antigen Specific Immunotherapy for Celiac Disease.NAICS 541714, PSC AN12 | $0 |
- Places of performance
- Pennsylvania
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards